Introduction {#S0001}
============

Mastitis, defined as inflammation of the mammary gland, causes severe economic loss in the dairy industry due to decreased milk production, decreased reproductive performance, additional costs for treatments, and the increased risk of culling or death of the affected animals.[@CIT0001] Moreover, milk from dairy cows with mastitis represents a food issue and thus maybe a threat to human health. Pathogens, such as *Streptococcus uberis, Escherichia coli*, and coagulase-positive staphylococci (CPS), are implicated as the causative agents of mastitis.[@CIT0002],[@CIT0003]

*Staphylococcus aureus*, a member of CPS, usually inhabits the skin and mucosal surfaces of humans and animals but can also be found in the environment. *Staph. aureus* leads to a variety of diseases in humans, is associated with nosocomial morbidity and mortality,[@CIT0004] and it has been regarded as a major pathogen in leading to bovine mastitis.[@CIT0005] It is important to study the clonal origin of *Staph. aureus* isolated from milk samples of dairy cows with mastitis because it may provide information about pathogen-associated factors.[@CIT0006] Notably, *spa* typing is a standardized method for distinguishing *Staph. aureus* isolates from different areas around the world. As previously reported, t529, t267 and t359 were three main *spa* types identified in Canada, India, the USA and Germany.[@CIT0007] However, the predominant *Staph. aureus spa* type in the Liaoning Province of China has rarely been reported.

Antimicrobial agents, such as β-lactams, tetracyclines, and some quinolones, are used to treat bovine mastitis in China;[@CIT0008] however, the β-lactams penicillin, oxacillin, and ceftiofur and the fluoroquinolone enrofloxacin are mainly used to treat bovine mastitis in the Liaoning Province of China (data unpublished). *S. aureus* isolates, however, have developed resistance to a variety of antimicrobial agents, particularly penicillin, ampicillin, erythromycin, and tetracycline.[@CIT0008]

Several studies have been conducted to investigate the prevalence of antibiotic resistance in *Staph. aureus* isolates from dairy cows with mastitis in China.[@CIT0009],[@CIT0010] Unfortunately, very few studies have been performed to investigate the antimicrobial resistance of *Staph. aureus* in the Liaoning Province of China. The study could be improved by comparing the antibiotic resistance of *Staph. aureus* isolates from the Liaoning Province to those from other provinces in China.

*Staph. aureus* infections that lead to mastitis in dairy cows are associated with the expression of a variety of virulence factors.[@CIT0007] These virulence factors allow *Staph. aureus* to adhere to the mucosal surface, avoid elimination by the host's immune system, and ultimately lead to infection of the host. For example, the virulence gene *hlb* allows organisms evade the host's immune system by encoding for hemolysin beta; several virulence genes such as *clfA, clfB, fnbA* and *fnbB* are involved in the process of cell surface adhesion, which is a crucial step in establishing infection; many *Staph. aureus* isolates also possess genes that code for superantigens, such as toxic syndrome toxin-1 related gene (*tsst-1*) and heat-stable enterotoxins related genes (*sea, seb, sec, sed*, and *seg*).[@CIT0011] Therefore, the objective of this study was to determine the antimicrobial resistance of *Staph. aureus* isolates from dairy cows with mastitis in the Liaoning Province of China, and to investigate their virulence gene distribution and biofilm production.

Materials and Methods {#S0002}
=====================

Sample Collection {#S0002-S2001}
-----------------

All the milk samples were collected between March 2016 and October 2016 using an aseptic technique as previously reported.[@CIT0012] Briefly, the teats were cleaned using towels and disinfected with 75% ethanol; immediately following disinfection, approximately 3 mL of milk was collected from each quarter of the udder by veterinarians who previously received training on the procedures for sampling as well as how to diagnose clinical mastitis and subclinical mastitis. All of the samples were stored in a cooler box containing ice and were transported to the laboratory within 6 h of collection.

To obtain a representative sample of the herds in the Liaoning Province, we selected the farms for this study according to the following criteria: (i) the farm had a minimum of 105 lactating cows, (ii) the average milk production was above 5500 kg of milk per cow per year, (iii) the cows were milked twice daily at 4:00 a.m. and 4:00 p.m., (iv) the cows were primarily Holstein and Chinese Holstein (hybrid of Holstein and Yellow cattle); additionally, we selected at least two herds in the north, middle and south regions of the Liaoning Province to carry out our experiment. Milk samples from dairy cows with mastitis were obtained from seven herds in total from three districts (2 herds in Shenyang, which is located in the middle of the Liaoning Province, 2 herds at Fuxin, which is located in the northern part of the Liaoning Province; and 3 herds at Wafangdian, which is located in the southern part of the Liaoning Province), and the mean herd size was 181. All of the *Staph. aureus* isolates used in this study were collected from milk samples from dairy cows with clinical mastitis (n=186; which includes 55 milk samples from Shenyang; 51 milk samples from Fuxin; 80 milk samples from Wafangdian) or subclinical mastitis (n=276; which includes 84 milk samples from Shenyang; 77 milk samples from Fuxin; 115 milk samples from Wafangdian). Each farm's veterinarian diagnoses clinical mastitis according to previous reports.[@CIT0013] Briefly, the veterinarian examined the cow for signs of systemic illness, measured its rectal temperature, and examined the milk for signs of clinical mastitis. Clinical mastitis was defined as at least one of the following symptoms, clots in the milk, elevated udder temperature, or swelling of the udder. For this study, the mastitic cows had received no systemic or local treatment by antimicrobial agents within the last 15 days. For subclinical mastitis, the California mastitis test was initially used as a diagnostic technique to determine whether the bovine was undergoing subclinical mastitis (scored as -, +, ++, and +++, corresponding to negative, weak positive, positive, and strong positive, respectively), and then a somatic cell count (SCC) was determined using a Fossomatic FC (Foss, Hilleroød, Denmark) to confirm the result. The bovine was considered to be undergoing subclinical mastitis if the SCC of the milk samples from a mammary quarter were higher than 200,000.[@CIT0014] The SCC was carried out in duplicated quarter milk samples to confirm whether the cow was undergoing a subclinical mastitis.

*Staph. aureus* Isolates {#S0002-S2002}
------------------------

*Staph. aureus* was isolated from milk samples according to the National Mastitis Council guidelines.[@CIT0015] In short, 10 µl of each milk sample was streaked onto an Aureus ChromoSelect Agar Base (Sigma, Shanghai, China) that contained one vial of polymyxin B per 500 mL (Sigma, Shanghai, China). The plates were incubated at 37 ºC for 48 h, and then single colonies that were a brownish to blackish color were isolated and cultured.[@CIT0016] The suspected colonies were initially identified by appearance, Gram staining, catalase testing, and coagulase testing (rabbit plasma tube test, TransGen, Beijing China). Finally, the isolates were identified using the API Staph system (Mérieux, Shanghai, China). A pure culture of each isolate was stored at −80 ºC in cryogenic vials (Biologix, Shandong, China), that contained 1 mL of trypticase soy broth (AoBox, Beijing, China) and 30% glycerin (Solarbio, Beijing, China).

DNA Extraction {#S0002-S2003}
--------------

The stored cultures were streaked onto Mueller-Hinton agar (MH(A), AoBox, Beijing, China) containing 5% sterile defibrinated sheep blood (Land Bridge, Beijing, China) and were incubated at 37 ºC for 24 h. Then, a single colony was isolated, inoculated into 3 mL of sterile MH(B) (AoBox), and cultured at 37 ºC for 24 h in an incubator (Thermo Fisher, Shanghai, China). The overnight culture was centrifuged at 3000 × *g* (ThermoFisher, Shanghai, China), and the supernatant was discarded. The precipitate was resuspended in phosphate buffer saline (PBS, pH=7.4; Solarbio, Beijing, China) containing 20 mg/mL lysostaphin (Sigma, Shanghai, China). The suspension was incubated at 37 ºC for 30 min. DNA extraction was carried out using a bacterial DNA extraction kit (TaKaRa, Dalian, China) according to the manufacturer's protocol. All of the DNA preparations were stored at −20 ºC until subsequent use.

*Spa* Typing {#S0002-S2004}
------------

The primers *spa*-1113F and *spa*-1514R were used to amplify the polymorphic X region of the *spa* gene ([Table 1](#T0001){ref-type="table"}). Briefly, the *spa* gene was amplified by a Bio-Rad S1000 system (Bio-Rad, CA, USA) using Ex Taq^®^ DNA polymerase (TaKaRa, Dalian, China). Each reaction mixture (25 μL) contained 2.5 μL of 10 × Ex Taq buffer (containing 3 mM MgCl~2~), 100 μM dNTP mixture, 200 nM of each primer, 0.63 U of Ex Taq, and 10 ng of chromosomal DNA. The PCR products were resolved by electrophoresis in 1.0% agarose gels in a 0.5 × Tris-acetate-EDTA buffer (Solarbio, Beijing, China); the bands were visualized using the System GelDoc XR+ (Bio-Rad, CA, USA) after being stained with GoldView (Solarbio). The PCR amplicons were purified using the MiniBEST DNA Fragment Purification Kit (TaKaRa, Dalian, China) and then sequenced; the *spa* types were determined using the *spa*-server ([<http://spa.ridom.de/>]{.ul}).[@CIT0017]Table 1Primer Sequences and PCR Conditions Used in This StudyPrimersPrimer Sequence (5ʹ→3ʹ)Program^a^Size of PCR Product (bp)Reference*spa-1113*FTAAAGACGATCCTTCGGTGAG1VariableAires-de-Sousa et al 2006[@CIT0040]*spa-1514*RCAGCAGTAGTGCCGTTTGCTT*seaF*TTGGAAACGGTTAAAACGAA2120Park et al, 2011[@CIT0042]*seaR*GAACCTTCCCATCAAAAACA*sebF*TCGCATCAAACTGACAAACG2478Park et al, 2011[@CIT0042]*sebR*GCAGGTACTCTATAAGTGCC*secF*GCATAAAAGCTAGGAATTT2257Park et al, 2011[@CIT0038]*secR*AAATCGGATTAACATTATCC*sedF*CTAGTTTGGTAATATCTCCT2317Park et al, 2011[@CIT0042]*sedR*TAATGCTATATCTTATAGGG*segF*AATTATGTGAATGCTCAACCCGATC2642Park et al, 2011[@CIT0042]*segR*AAACTTATATGGAACAAAAGGTACTAGTTC*tsst-1F*ATGGCAGCATCAGCTTGATA2350Park et al, 2011[@CIT0042]*tsst-1R*TTTCCAATAACCACCCGTTT*bbpF*AACTACATCTAGTACTCAACAACAG3575Tristan et al, 2003[@CIT0043]*bbpR*ATGTGCTTGAATAACACCATCATCT*cnaF*GTCAAGCAGTTATTAACACCAGAC3423Tristan et al, 2003[@CIT0043]*cnaR*AATCAGTAATTGCACTTTGTCCACTG*fnbAF*GTGAAGTTTTAGAAGGTGGAAAGATTAG4643Tristan et al, 2003[@CIT0043]*fnbAR*GCTCTTGTAAGACCATTTTTCTTCAC*fnbBF*GTAACAGCTAATGGTCGAATTGATACT4524Tristan et al, 2003[@CIT0043]*fnbBR*CAAGTTCGATAGGAGTACTATGTTC*clfAF*ATTGGCGTGGCTTCAGTGCT4292Tristan et al, 2003[@CIT0043]*clfAR*CGTTTCTTCCGTAGTTGCATTTG*clfBF*ACATCAGTAATAGTAGGGGGCAAC4205Tristan et al, 2003[@CIT0043]*clfBR*TTCGCACTGTTTGTGTTTGCAC*hlaF*CTGATTACTATCCAAGAAATTCGATTG5209Jarraud et al, 2002[@CIT0041]*hlaR*CTTTCCAGCCTACTTTTTTATCAGT*hlbF*GTGCACTTACTGACAATAGTGC5309Jarraud et al, 2002[@CIT0041]*hlbR*GTTGATGAGTAGCTACCTTCAGT*hldF*AAGAATTTTTATCTTAATTAAGGAAGGAGTG5111Jarraud et al, 2002[@CIT0041]*hldR*TTAGTGAATTTGTTCACTGTGTCGA*hlgAF*GTCAYAGAGTCCATAATGCATTTAA5535Jarraud et al, 2002[@CIT0041]*hlgAR*CACCAAATGTATAGCCTAAAGTG*lukAF*GAAGTATCTAATACTTCTTTAGCAGC6625da Costa et al, 2014[@CIT0034]*lukAR*TCATTTGACAATTCTACACTTCCAAC*lukBF*TGAAAAAGGTTCAAAGTTGATACGAG6433da Costa et al, 2014[@CIT0034]*lukBR*TGTATTCGATAGCAAAAGCAGTGCA[^1]

Antimicrobial Susceptibility Test {#S0002-S2005}
---------------------------------

"The antibiotic resistance phenotype was determined using the microdilution method in MH(B) broth (AoBox) according to the Clinical Laboratory and Standards Institute (CLSI) guidelines.[@CIT0018] For each isolate, five colonies from the agar medium were inoculated into the broth medium in order to reach adequate growth; the inoculums were then transferred into tubes containing sterile 0.85% saline (Solarbio, Beijing, China), and the inoculums were mixed with the saline. The turbidity was adjusted using sterile saline (Solarbio) to equal a 0.5 McFarland standard, by comparing turbidity under a light source to observe two tubes side by side. The trays were maintained in an incubator with normal atmosphere for 24 h at 37 ºC, and *Staph. aureus* ATCC 25923 was used as the reference strain. Breakpoints for different antimicrobial agents are shown in [Table 2](#T0002){ref-type="table"}." Table 2Dilution Range and Susceptibility Breakpoints of Antimicrobial Agents Used in This StudyAntimicrobial AgentDilution Range (μg/mL)Susceptibility Break Points (μg/mL)SusceptibleIntermediateResistantPenicillin^a^0.03--64≤0.12≥0.25Oxacillin^b^0.03--64≤2≥4Sulfamethoxazole^a^0.12--128≤64≥128Tetracycline^a^0.03--64≤48≥16Enrofloxacin^a^0.03--16≤0.250.5--1≥2Amoxicillin/clavulanate^b^0.03--64≤22/4≥8Cefalexin^d^0.03--64≤24≥8Ceftiofur^a^0.03--64≤2^4^4≥8Clindamycin^b^0.03--64≤21--2≥4Daptomycin^c^0.03--64≤11--2≥2[^2]

The following antimicrobial agents were purchased from the Chinese Institute of Veterinary Drug Control (Beijing, China): amoxicillin/clavulanate (the ratio for amoxicillin:clavulanate is 4:1, the purity of amoxicillin and clavulanate is 98% and 94%, respectively), cefalexin (95% pure), cefquinome (80% pure), ceftiofur (98% pure), clindamycin (80% pure), daptomycin (78% pure), enrofloxacin (94.2% pure), oxacillin (93.7% pure), penicillin (84.6% pure), tetracycline (73.92% pure), sulfamethoxazole/trimethoprim (the ratio for sulfamethoxazole:trimethoprim is 20:1, the purity of sulfamethoxazole and trimethoprim is 93.2% and 81.36%, respectively), and gentamicin (61.57% pure).

Detection of Virulence Genes {#S0002-S2006}
----------------------------

Multiplex polymerase chain reaction (Multiplex PCR) was used to screen the distribution of the following virulence factors as previously reported: 6 cytotoxins (*hla, hlb, hld, hlgA, lukA*, and *lukB*), 6 adhesion factors (*bbp, clfA, clfB, cna, fnbA*, and *fnbB*), and 6 enterotoxins (*sea, seb, sec, sed, seg*, and *tsst-1*). The primers used are shown in [Table 1](#T0001){ref-type="table"}.

Briefly, multiplex PCR was carried out by a Bio-Rad S1000 system (Bio-Rad) using Ex Taq^®^ DNA polymerase (TaKaRa). Each reaction mixture (50 μL) contained 5 μL of 10 × Ex Taq buffer (containing 3 mM MgCl~2~), 100 μM dNTP mixture, 200 nM of each primer, 1.25 U of Ex Taq, and 10 ng of chromosomal DNA. The PCR products were resolved by electrophoresis in 2.0% agarose gels in a 0.5 × Tris-acetate-EDTA buffer (Solarbio), were stained with GoldView (Solarbio), and then were visualized using the System GelDoc XR+ (Bio-Rad).

Adhesion Testing {#S0002-S2007}
----------------

Biofilm formation was measured as previously reported using spectrophotometry with crystal violet staining.[@CIT0019] All *Staph. aureus* isolates were streaked onto tryptic soy agar plates (TSB; AoBox, Beijing, China), and incubated at 37 ºC for 18 h. Five colonies were inoculated into a brain heart infusion (BHI; AoBox, Beijing, China) containing 0.25% glucose (Solarbio, Beijing, China) to obtain a 0.5 McFarland standard (approximately 1.5 × 10^8^ CFU/mL). One-hundred microliters was transferred into the wells of a 96-well microtiter plate (ThermoFisher, Shanghai, China), and 100 μL BHI medium (AoBox) containing 0.25% glucose (Solarbio) was added into each well. The plates were stored in an incubator (ThermoFisher) at 35 ºC for 24 h under aerobic conditions without agitation. The plates were slightly washed three times with 200 μL of phosphate buffer saline (PBS, pH=7.4; Solarbio) after discarding the supernatant. The plates were then dried and stained with 0.1% (w/v) crystal violet (Sigma, Beijing, China) for 30 min. Each well was washed three times with 200 μL of water and then dried again. Two hundred microliters of 95% ethanol (Anpel, Shanghai, China) was added to each well, and the plate was incubated at room temperature for 1 h with frequent agitation. A plate reader (BioRad, CA, USA) was used to measure the absorbance of each well at 560 nm. To avoid variations between different plates, the reference strain ATCC 29740 was used to normalize each plate.[@CIT0019] Each experiment was carried out at least three times. The biofilm formation for each isolate was calculated and normalized by dividing the average biofilm formation for each isolate by the biofilm production of the reference strain. Then, the normalized biofilm formation was calculated based on the three independent assays.

Confocal Laser Scanning Microscopy Observation {#S0002-S2008}
----------------------------------------------

Biofilms were observed using an Olympus FV1000-IX81 inverted confocal microscope equipped with a 60 × oil immersion lens (Olympus, Tokyo, Japan) as previously reported.[@CIT0020] Briefly, 3 to 5 colonies were inoculated into TSB broth (AoBox) and incubated at 37ºC for 18 h. Two-milliliter aliquots of inocula, which were diluted to 10^5^ and 10^6^ CFU/mL, were transferred to 35-mm-diameter glass bottom petri dishes (ThermoFisher, Shanghai, China). After incubation for 18 h, the TSB broth (AoBox) was removed by washing with phosphate buffer saline (pH=7.4, Solarbio), and the biofilms were stained using the LIVE/DEAD BacLight Bacterial Viability kit (ThermoFisher, Shanghai, China) according to the kit instructions. Biofilms were imaged using an inverted confocal microscope (Olympus). The SYTO 9 dye was excited by a 488-nm argon laser, and emitted light was collected at 520 nm. The propidium iodide dye was excited by a 559-nm argon laser, and emitted light was collected at 619 nm.

Statistical Analysis {#S0002-S2009}
--------------------

The values from adhesion testing by *spa* types were compared using an ANOVA test. These data were first analyzed using a repeated measure ANOVA, and then the Fisher protected least significant difference test was performed. For all analyses, *P*\<0.05 was considered significant, and values are presented as the mean ± SEM.

Results {#S0003}
=======

Prevalence of *Staph. aureus* {#S0003-S2001}
-----------------------------

In this study, 12.12% (56/462) of milk samples obtained from dairy cows with mastitis were positive for *Staph. aureus*, including 13.97% (26/186) of milk samples from dairy cows with clinical mastitis and 10.86% (30/276) of milk samples from dairy cows with subclinical mastitis.

### *Spa*Typing {#S0003-S2001-S3001}

The 53 *Staph aureus* isolates belonged to 8 *spa* types ([Table 3](#T0003){ref-type="table"}), but three isolates were nontypable because PCR amplification was not achieved. The main types (n≥5) were t267 (n=19), t730 (n=12), t518 (n=8), t1190 (n=6), and t1456 (n=5).Table 3*Spa* Type and Biofilm Production of the *Staph. Aureus* IsolatesSpa TypeNumber of IsolatesBiofilm Formationt267191.07±0.16t730120.38±0.12t51881.02±0.29t119060.67±0.17t145650.46±0.19t22411.14±0.37t912910.42±0.15t17710.64±0.24

Antimicrobial Resistance of *Staph. aureus* Isolates {#S0003-S2002}
----------------------------------------------------

The results of the antimicrobial susceptibility measurement of *Staph. aureus* isolates are shown in [Table 4](#T0004){ref-type="table"}. All of the isolates were nonsusceptible to sulfamethoxazole, and forty-three (76.79%) of the isolates were nonsusceptible to penicillin and daptomycin. Additionally, most of the isolates were also nonsusceptible to oxacillin (34/56, 60.71%), clindamycin (39/56, 69.64%), and enrofloxacin (28/56, 50%). Only 11 (19.6%) isolates were nonsusceptible to amoxicillin/clavulanate. Notably, oxacillin showed a wide range of MIC distributions and exhibited a high antibiotic resistance rate. Moreover, 85.71% (48/56) of the isolates were nonsusceptible to at least three of the antimicrobial agents, and 23 out of the 56 isolates were nonsusceptible to five or more of the antimicrobial agents.Table 4Minimum Inhibitory Concentrations (μg/mL) of the *Staph. Aureus* Isolates from the Milk of Dairy Cows with Mastitis (56 Isolates)![](IDR-13-1365-i0001.jpg){#ILF0001}[^3]

Prevalence and Distribution of the Virulence Genes {#S0003-S2003}
--------------------------------------------------

Among the *Staph. aureus* isolates, the detection rates for *clfA, clfB, fnbB*, and *cna* were 89.29% (50/56), 89.29% (50/56), 80.36% (45/56), and 8.93% (5/56), respectively. Conversely, genes *bbp* and *fnbA* were negative in all of the isolates. High detection rates were detected for *hla* (53/56, 94.64%) and *hlb* (50/56, 89.29%) among the *Staph. aureus* isolates; however genes encoding for other cytotoxins, including *hld, hlgA, lukA*, and *lukB*, were negative in all of the isolates. Of the 56 isolates, 23 isolates (41.07%) were found to have one or more genes that encode for enterotoxins. Isolates with *seg* (15/56, 26.79%) were the most prevalent followed by those with *sea* (9/56, 16.07%), *seb* (4/56, 7.14%), and *sec* (4/56, 7.14%). However, all of the isolates were negative for both *sed* and *tsst-1* in this study.

Adhesion Testing {#S0003-S2004}
----------------

Biofilm formation was determined in vitro using the crystal violet staining method. A total of 53 out of the 56 isolates were compared (the nontypable strains were not included). The average biofilm formation for each *spa* type is shown in [Table 3](#T0003){ref-type="table"}. The biofilm production of t267 was elevated in comparison with t730 (*P*\<0.001), t1190 (*P*\<0.001), t1456 (*P*\<0.001), t9129 (*P*\<0.001), and t177 (*P*=0.003), but t267 showed a similar biofilm production ability as t518 and t224. The distribution of biofilm production for each *spa* type is presented in [Figure 1](#F0001){ref-type="fig"}.Figure 1Boxplots of the in vitro biofilm production of *Staph. aureus* strains of the major *spa* types (n≥5). Each dot represents one strain. Biofilm production was different among the main *spa* types, especially *spa* types t730 and t1456, which produced less biofilm than the other main *spa* type. Significance was determined by an ANOVA test (\* *P*\<0.05; \*\* *P*\<0.01).

Confocal laser scanning microscopy was used to observe the biofilm production of the *Staph. aureus* isolates, and the results indicated that these isolates possessed a variety of biofilm production ([Figure 2](#F0002){ref-type="fig"}). The SA0020 ([Figure 2D](#F0002){ref-type="fig"}), SA0028 ([Figure 2F](#F0002){ref-type="fig"}), and SA0031 ([Figure 2G](#F0002){ref-type="fig"}) isolates grew biofilm with a tower-shaped structure, and the SA0023 ([Figure 2E](#F0002){ref-type="fig"}) and SA0047 ([Figure 2H](#F0002){ref-type="fig"}) isolates could produce thicker biofilm in comparison with the other isolates.Figure 2Confocal laser scanning microscopy of in vitro biofilm production of *Staph. aureus* isolates. The biofilms were stained with LIVE/DEAD stain. Green represents live cells, red represents dead cells and eDNA, and yellow represents a mixture. (**A**) SA0007; (**B**) SA0012; (**C**) SA0019; (**D**) SA0020; (**E**) SA0023; (**F**) SA0028; (**G**) SA0031; (**H**) SA0047; (**I**) SA0052.

Discussion {#S0004}
==========

Cow mastitis is a common infectious disease found all over the world, which leads to huge economic losses. A variety of factors can cause mastitis in dairy cows, including bacteria, viruses, fungi, and mycoplasma; however, *Staph. aureus* is one of the most frequently isolated etiological agents.[@CIT0021] In this study, we characterized 56 *Staph. aureus* isolates from milk samples of bovine mastitis in the Liaoning province of China. The *Staph. aureus* isolates were non-susceptible to a variety of antimicrobial agents, including sulfamethoxazole, penicillin, daptomycin, oxacillin, and clindamycin; however, the majority of the isolates were susceptible to amoxicillin/clavulanate. The virulence gene patterns did not differ systematically among the herds, eg *hla, hlb, clfA, clfB*,and *fnbB* were the predominant virulence genes found among all of the herds. The t267 *spa* type was the most *spa* type identified among all of the isolates and exhibited the highest biofilm production; whereas the t730 *spa* type exhibited the lowest biofilm formation; biofilm formation was also often associated with tower-shaped structures or thicker biofilm.

*Staph. aureus* is considered an important factor in causing mastitis in China.[@CIT0022]--[@CIT0024] Our study indicated that 12.12% (56/462) of milk samples obtained from seven dairy farms in the Liaoning Province of China were positive for *Staph. aureus*. This prevalence is similar to previous reports from China and eastern Poland.[@CIT0009],[@CIT0024],[@CIT0025] Conversely, recent studies indicated that the rates of *Staph. aureus* in milk samples from bovine mastitis in Beijing and Jiangsu were 46.2% and 29.0%, respectively;[@CIT0023],[@CIT0024] 41.7% of milk samples from dairy cows with clinical mastitis were positive for *Staph. aureus* in Northern Ethiopia;[@CIT0026] and *Staph. aureus* were identified among 21% of dairy cows in the Republic of Ireland.[@CIT0027] We speculate that better sanitation in herds, increased surveillance, and more control over *Staph. aureus* infections may contribute to the observed discrepancy, and thus, additional epidemiological investigation needs to be carried out to monitor the occurrence of bovine mastitis caused by *Staph. aureus*. An increased SCC was noticed in all isolates from both the clinical and subclinical mastitis samples. Clinical mastitis exhibited either a modest or pronounced increase in the SCC (with a mean SCC of 7.51×10^5^ cells/mL); however, subclinical mastitis showed a weak increase (with an average SCC of 3.23×10^5^ cells/mL). An elevated SCC is normally indicative of a severe infection within the udder and is usually associated with severe symptoms, including clots in the milk, elevated udder temperature, and/or swelling within the udder. However, no correlation has been observed between the *spa*-types and the SCC or clinical symptoms.

Antimicrobial susceptibility testing can provide information aid in choosing antibiotics for the treatment of bovine mastitis caused by *Staph. aureus*. In this study, high resistance to antimicrobial agents was observed in the *Staph. aureus* isolates; similarly, as previously reported, 47.15% of *Staph. aureus* isolates were nonsusceptible to 3 or more antimicrobial agents in north east of India.[@CIT0028] However, a much lower resistance rate to antimicrobial agents was observed in the United States and European countries.[@CIT0029] We speculate that the herd size may contribute to this discrepancy because farms with larger herd sizes normally have more dairy cows, there is often more residue in the environment within a herd due to the use of antimicrobial agents to treat bovine mastitis; thus, the pressure for pathogens to become resistant is increased. Recent reports indicated that *Staph. aureus* isolates from bovine mastitis have the highest resistance rate to penicillin (ranging from 10% to 80%),[@CIT0024] and similar results were achieved in our study (76.79%). In contrast, a considerably lower resistance rate to penicillin (33.33%) was reported by Rabello et al in Brazil.[@CIT0030] The reason for this phenomenon is that penicillin is normally used to treat bovine mastitis during the dry period, thus *Staph. aureus* is under extensive pressure to become resistant to penicillin. Moreover, the resistance patterns were different between the different dairy farms. For example, most of the *Staph. aureus* isolates from farm A were resistant to enrofloxacin, while those from farm B in Fuxin showed no resistance to enrofloxacin. This data indicated that the veterinarian in farm A may prefer to use enrofloxacin when treating infections, and thus, there was increased pressure for *Staph. aureus* to become resistant to enrofloxacin. Therefore, attention should be paid to the rational management and appropriate usage of antimicrobial agents in these herds, which has been reported to be important in the control and prevention of the transmission of antimicrobial resistance.[@CIT0031]

Virulence genes are vital for bacterial pathogenicity. *Staph. aureus* isolates from cows with mastitis were reported to harbor different enterotoxin genes, indicating that these toxins are important in the development of mastitis.[@CIT0032] Consistent with previous reports, the adhesion genes *clfA, clfB*, and *fnbB* were the most prevalent in our study; however, Gogoi-Tiwari et al found *fnbB* only in 1.3% of *Staph. aureus* isolates,[@CIT0033] which was much lower than the rate found in our study (80.36%). Genes encoding for the adhesion factors *clfA* and *clfB* were more prevalent in comparison with other virulence genes; we share the same speculation with previous researchers that these adherence genes may be involved in the initial attachment of *Staph. aureus* to the epithelial cells of the teat canal and have become dominant in these herds.[@CIT0034] In the present study, none of the 56 *Staph. aureus* isolates from bovine mastitis were positive for the *tsst* gene; however, 30% of the clinical isolates contained the *tsst* gene in a previous report.[@CIT0023] The classic enterotoxin staphylococcus enterotoxin (SE) was also detected in this study, which is believed to cause food poisoning incidents. In our study, however, fewer isolates were positive for SEs genes in comparison with that from a previous report (46.42% vs 89.7%).[@CIT0035] The *seg* gene was the most prevalent gene found in our study, while Wang et al reported that the *sec* (65.6%) and the *sea* (60.4%) genes were the most frequently detected genes;[@CIT0024] moreover, another Chinese study reported that the *seb* gene was the most commonly detected.[@CIT0009] A previous study indicated that genotype B and genotype C were the most common genotypes found in bovine intramammary infections; genotype B was typically positive for *sea, sed*, and *sej*, but genotype C strains were positive for *sec, seg, sei*, and *tst*, but negative for *sea, sed*, and *sej*.[@CIT0036] We speculate that virulence gene patterns of *Staph. aureus* have variable distributions among herds from different regions because of local strain evolution.

Biofilm can protect bacteria from a variety of hazards, especially when bacteria are challenged with antibiotics. Biofilms decrease the amount of antibiotics that are able to reach the inner layer of the biofilm.[@CIT0037] Usually, the bacteria located within the inner layer are less susceptible to the antibiotics because they metabolize slowly.[@CIT0038] Our study analyzed the *spa* types in the isolates; t267 was the most prevalent *spa* type, but a recent study indicated that t267 was mainly located in cow nostrils.[@CIT0021] In this study, we mainly collected the milk samples in summer, so we speculate that flies may play an important role in the dissemination of these pathogens, leading to bovine mastitis. However, a previous report indicated that the t127 and t2279 *spa* types were the top two frequently distributed genotypes in milk samples.[@CIT0039] Therefore, we speculate that *Staph. aureus* isolates from different areas may belong to various *spa* types. The t267 *spa* type showed the highest ability to produce biofilm, which was also confirmed by Pichette-Jolette's report.[@CIT0007] When observed under confocal laser scanning microscopy, the biofilm of the *Staph. aureus* isolates showed a tower-shaped structure, and some of the isolates produced a thicker biofilm. Similarly, *Staph. aureus* USA300 can produce biofilms with a more tower- and pillar-shaped structure when cultured in low-dose amoxicillin in comparison with their biofilm when grown in the absence of antibiotic.[@CIT0020]

Conclusion {#S0005}
==========

Our study provides an epidemiological survey on the prevalence of *Staph. aureus* in dairy cows with mastitis in the Liaoning Province of China. The *Staph. aureus* isolates were resistant to many β-lactams except ceftiofur and amoxicillin/clavulanate; speculate that this phenomenon may be caused by the priority of clinical applications when choosing antimicrobial agents. The predominant *spa*-type was t267, which exhibited severe antimicrobial resistance to penicillin, oxacillin, and enrofloxacin and harbored the virulence genes *clfA, clfB, fnbB, hla*, and *hlb*; this suggests that this *spa*-type is capable of adhesion to the teat leading to bovine mastitis. Our results suggest a need for continuous monitoring of the antimicrobial resistance, virulence phenotypes, and adhesion ability of *Staph. aureus* isolates from bovine mastitis. Additionally, data about antimicrobial agent management practices, which may influence antimicrobial resistance in bovine mastitis, should be collected in the Liaoning Province of China.
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[^1]: **Notes:** ^﻿a^PCR program. 1: 1×(94ºC, 600s), 30×(94ºC, 20s, 62ºC, 20s, 72ºC, 30s), 1×(72ºC, 600s). 2: 1×(94ºC, 600s), 35×(94ºC, 60s, 55ºC, 60s, 72ºC, 60s), 1×(72ºC, 300s). 3: 1×(94ºC, 600s), 30×(94ºC, 60s, 58ºC, 120s, 72ºC, 60s), 1×(72ºC, 600s). 4: 1×(94ºC, 600s), 30×(94ºC, 60s, 52ºC, 60s, 72ºC, 60s), 1×(72ºC, 600s). 5: 1×(94ºC, 180s), 35×(94ºC, 60s, 60ºC, 60s, 72ºC, 180s), 1×(72ºC, 420s). 6: 1×(94ºC, 180s), 35×(94ºC, 60s, 57ºC, 60s, 72ºC, 180s), 1×(72ºC, 420s).

[^2]: **Notes:** ^﻿a^Interpretative breakpoint based on the CLSI breakpoints used in veterinary medicine; ﻿^b^﻿interpretative breakpoint based on the CLSI breakpoints used in human medicine; ﻿^c^﻿interpretative break point based on EUCAST, 2015;[@CIT0044] ﻿^d^﻿breakpoint of cefalexin based on cephalothin.

[^3]: **Notes:** The dilution ranges tested are those contained within the light blue area, and the concentrations of the different antimicrobial agents are illustrated in the light gray area. The breakpoints were employed according to VET01S, 3rd ed, human, daptomycin was interpreted according to EUCAST, and the breakpoint of cefalexin was based on cephalothin. When available, susceptible and resistance breakpoints are indicated by the vertical green and red line, respectively. The dashed vertical green line represents the breakpoints from humans.
